Agreement allows for a range of potentially best-in-class therapy options as monotherapy and fixed dose combination with Roche`s lead incretin...
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing...
RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing...
UTRECHT, Netherlands, March 12, 2025 /PRNewswire/ -- Turacoz Group, a leader in real-world evidence (RWE) and health economics and outcomes...
DUBAI, UAE, March 12, 2025 /PRNewswire/ -- XRP Healthcare, a pioneering force in healthcare innovation, has officially acquired Pharma Ville,...
$250,000 top award goes to Matteo Paz in America's longest running and most distinguished science and math competition TARRYTOWN, N.Y. and WASHINGTON,...
A curated selection of common product configurations from the previously configure-to-order product line is now available off-the-shelf at RS Americas....
Next-Gen Therapies and Data-Driven Innovation Take Center Stage as Industry Leaders Explore AI-Led Patient-Centric Strategies to Revolutionize Drug Commercialization BERKELEY...
Distinguished U.S. Experts and Global Industry Leaders Join Newly Formed Advisory Board to Drive Strategic Growth and Innovation BRISBANE, Australia and...
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany...
Powered by the Veeva Development Cloud, the system brings together previously disparate functions to streamline the medicinal development process and...
Investment Reinforces Woodstock’s Commitment to Growth and Operating Efficiency Woodstock Sterile Solutions Woodstock Sterile Solutions is expanding its BFS capabilities...
LA JOLLA, CA, March 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for...
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development...
DOYLESTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
FLORHAM PARK, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people...
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE)...
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO,...